Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 15:1280:135071.
doi: 10.1016/j.molstruc.2023.135071. Epub 2023 Feb 1.

Chemistry and Pharmacological diversity of Benzothiazepine - Excellent pathway to drug discovery

Affiliations

Chemistry and Pharmacological diversity of Benzothiazepine - Excellent pathway to drug discovery

Temitope A Ogunnupebi et al. J Mol Struct. .

Abstract

In this era of sporadic advancement in science and technology, a substantial amount of intervention is being set in motion to reduce health-related diseases. Discoveries from researchers have pinpointed the usefulness of heterocyclic compounds, amongst which benzothiazepine (BTZ) derivatives have been synthesized for their various pharmacological activities. This also contributes to their undeniable application in therapeutic medicine for the development of efficacious drugs. BTZs are compounds with a benzene ring fused with a thiazepine ring. This work contains several methods that have been used to synthesize 1,3-, 1,4-, 1,5-, and 4-1-benzothiazepine derivatives. In addition, up-to-date information about the crucial pharmacological activities of BTZ derivatives has been reviewed in this present study to appreciate their druggable potential in therapeutic medicine for drug development. Drug design and development have further been simplified with the implementation of computer aided approaches to predict biological interactions which can help in the design of several derivatives. Hence, the structural activity relationship (SAR), ADMET and the molecular docking studies of BTZ derivatives were discussed to further establish their interactions and safety in biological systems. This present work aims to expound on the reported chemistry and pharmacological propensity of BTZ moiety in relation to other relevant moieties to validate their potential as excellent pharmacophores in drug design and development.

Keywords: ADMET; Drug design; Heterocyclic compounds; Medicinal properties; Molecular docking; Synthesis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no potential conflict of interest concerning the research, authorship, and/or publication of this article.

Figures

Figure 1:
Figure 1:
Different forms of the benzothiazepine ring
Figure 2:
Figure 2:
Structures of benzothiazepine with anti-tumor properties
Figure 3:
Figure 3:
Structures of benzothiazepine with anti-malaria properties
Figure 4:
Figure 4:
Structures of benzothiazepine with anti-bacterial properties
Figure 5:
Figure 5:
Structures of benzothiazepine with anti-fungal properties
Figure 6:
Figure 6:
Structures of benzothiazepine with anti-cancer properties
Figure 7:
Figure 7:
Structures of benzothiazepine with anti-protozoal properties
Figure 8:
Figure 8:
Structures of benzothiazepine with anti-diabetic properties
Figure 9:
Figure 9:
Structures of benzothiazepine with anti-oxidant properties
Figure 10:
Figure 10:
Structures of benzothiazepine with anti-anti-inflammatory properties
Figure 11:
Figure 11:
Structures of benzothiazepine with anti-leishmanial properties
Figure 12:
Figure 12:
SAR of 1,5-benzothiazepine derivatives containing pyridine moiety the antiviral activity
Figure 13:
Figure 13:
SAR of carbazole incorporated 1,5-benzothiazepine the antimalarial and antimicrobial activity
Figure 14:
Figure 14:
2D ligand interaction of compounds (a) 85 and (b) 86 against helicase of Zika virus protein.
Figure 15:
Figure 15:
2D ligand interaction (c) of compound 87 against EGFR kinase domain.
Figure 16:
Figure 16:
2D ligand interaction (d) of compound 88 against Tubulin.
Scheme 1:
Scheme 1:
Microwave synthesis of 1,4 benzothiazepine derivative
Scheme 2:
Scheme 2:
Microwave synthesis of 1,4-benzothiazepine derivative
Scheme 3:
Scheme 3:
Microwave synthesis of 1,5-benzothiazepine
Scheme 4:
Scheme 4:
Ultrasonic synthesis of 1,5-benzothiazepine
Scheme 5:
Scheme 5:
Ultrasonic synthesis of 2,4-substituted 1,5-benzothiazepine
Scheme 6:
Scheme 6:
Ultrasonic synthesis of 1,5-benzothiazepine
Scheme 7:
Scheme 7:
Solvent-free synthesis of 1,5-benzothiazepine derivatives
Scheme 8:
Scheme 8:
Synthesis of 1,5-benzothiazepine derivatives
Scheme 9:
Scheme 9:
Combinatorial synthetic route for 1,5-benzothiazepine derivatives
Scheme 10:
Scheme 10:
Synthesis of 1,3-Benzothiazepines derivative
Scheme 11:
Scheme 11:
Synthesis of 4,1-Benzothiazepines derivative
Scheme 12:
Scheme 12:
Rh-catalyzed reaction route of 1,5-Benzothiazepine derivatives
Scheme 13:
Scheme 13:
Synthesis of the 1,2-Benzothiazepine 1-Oxides derivative using Rh-catalyst
Scheme 14:
Scheme 14:
A 1,3 dipolar cycloaddition synthetic route for 1,5-benzothiazepine derivatives
Scheme 15:
Scheme 15:
Synthetic route for chloropyrazine conjugated 1,5-benzothiazepine derivatives
Scheme 16:
Scheme 16:
Synthetic route for furan attached to 1,4 benzothiazepine ring

Similar articles

Cited by

References

    1. Cabrele C, Reiser O. The Modern Face of Synthetic Heterocyclic Chemistry. J Org Chem. 2016;81(21):10109–10125. doi:10.1021/acs.joc.6b02034 - DOI - PubMed
    1. Zlotin SG, Churakov AM, Dalinger IL, et al. Recent advances in synthesis of organic nitrogen–oxygen systems for medicine and materials science. Mendeleev Commun. 2017;27(6):535–546. doi:10.1016/J.MENCOM.2017.11.001 - DOI
    1. Yet L. Introduction. In: Privileged Structures in Drug Discovery: Medicinal Chemistry and Synthesis. First. Jonh Wiley & Sons, Inc.; 2018:1–14.
    1. Nsanzabana C, Djalle D, Guérin PJ, Ménard D, González IJ. Tools for surveillance of anti-malarial drug resistance: An assessment of the current landscape. Malar J. 2018;17(1):1–16. doi:10.1186/s12936-018-2185-9 - DOI - PMC - PubMed
    1. Michael CA, Dominey-Howes D, Labbate M. The Antimicrobial Resistance Crisis: Causes, Consequences, and Management. Front Public Heal. 2014;2(SEP):1–8. doi:10.3389/fpubh.2014.00145 - DOI - PMC - PubMed

LinkOut - more resources